Spectral Medical Inc. (EDTXF)
EDTXF Stock Price Chart
Explore Spectral Medical Inc. interactive price chart. Choose custom timeframes to analyze EDTXF price movements and trends.
EDTXF Company Profile
Discover essential business fundamentals and corporate details for Spectral Medical Inc. (EDTXF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
IPO Date
18 Dec 2009
Employees
29.00
Website
https://www.spectraldx.comCEO
Christopher Seto
Description
Spectral Medical Inc., together with its subsidiaries, focuses on the development and commercialization of products for the treatment of septic shock and renal disease in North America. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops and manufactures monoclonal and polyclonal antibodies, recombinant cardiac proteins, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies; and develops platform for renal replacement therapy. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada.
EDTXF Financial Timeline
Browse a chronological timeline of Spectral Medical Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 7 May 2026
Upcoming earnings on 25 Mar 2026
Upcoming earnings on 7 Nov 2025
Earnings released on 8 Aug 2025
Revenue for the quarter reached $597.15K .
Earnings released on 9 May 2025
EPS came in at -$0.03 , while revenue for the quarter reached $401.65K .
Earnings released on 27 Mar 2025
EPS came in at $0.01 , while revenue for the quarter reached $448.21K .
Earnings released on 8 Nov 2024
EPS came in at -$0.03 , while revenue for the quarter reached $369.91K .
Earnings released on 9 Aug 2024
EPS came in at -$0.01 , while revenue for the quarter reached $344.50K , beating expectations by +29.31%.
Earnings released on 13 May 2024
EPS came in at -$0.01 , while revenue for the quarter reached $491.92K , beating expectations by +84.35%.
Earnings released on 28 Mar 2024
EPS came in at -$0.02 falling short of the estimated -$0.01 by -165.25%, while revenue for the quarter reached $274.82K , missing expectations by -47.15%.
Earnings released on 9 Nov 2023
EPS came in at -$0.01 matching the estimated -$0.01, while revenue for the quarter reached $293.10K , missing expectations by -43.64%.
Earnings released on 10 Aug 2023
EPS came in at -$0.01 matching the estimated -$0.01, while revenue for the quarter reached $231.00K , beating expectations by +5.00%.
Earnings released on 12 May 2023
EPS came in at -$0.01 falling short of the estimated -$0.01 by -35.32%, while revenue for the quarter reached $391.68K , beating expectations by +32.43%.
Earnings released on 24 Mar 2023
EPS came in at -$0.01 falling short of the estimated -$0.01 by -30.04%, while revenue for the quarter reached $389.78K .
Earnings released on 10 Nov 2022
EPS came in at -$0.01 falling short of the estimated -$0.01 by -20.05%, while revenue for the quarter reached $273.11K , missing expectations by -5.51%.
Earnings released on 12 Aug 2022
EPS came in at -$0.01 falling short of the estimated -$0.01 by -10.01%, while revenue for the quarter reached $222.04K , missing expectations by -52.34%.
Earnings released on 13 May 2022
EPS came in at -$0.01 matching the estimated -$0.01, while revenue for the quarter reached $387.13K , missing expectations by -19.27%.
Earnings released on 24 Mar 2022
EPS came in at -$0.01 matching the estimated -$0.01, while revenue for the quarter reached $405.44K , beating expectations by +2.57%.
Earnings released on 12 Nov 2021
EPS came in at -$0.01 falling short of the estimated -$0.01 by -20.05%, while revenue for the quarter reached $181.42K , missing expectations by -61.64%.
Earnings released on 13 Aug 2021
EPS came in at -$0.01 , while revenue for the quarter reached $450.98K .
Earnings released on 14 May 2021
EPS came in at -$0.01 falling short of the estimated -$0.01 by -30.04%, while revenue for the quarter reached $593.53K .
Earnings released on 26 Mar 2021
EPS came in at -$0.01 , while revenue for the quarter reached $419.09K .
Earnings released on 11 Nov 2020
EPS came in at -$0.01 , while revenue for the quarter reached $313.97K .
EDTXF Stock Performance
Access detailed EDTXF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.